Dr. Talia Kaden

Dr. Yannuzzi has made numerous innovative and lasting contributions in imaging, drug development, and therapeutic modalities. He was the first to use oral non-steroid anti-inflammatory medication for the treatment of cystoid macular edema and developed an eye drop to treat this condition. He has described new diseases as well as new associations and manifestations of established entities and photosensitization.He has published over 400 scientific papers and 13 books, which have earned him respect and admiration in the ophthalmic-retinal community and retina specialists internationally. He is well recognized as a devoted and excellent educator, a superb clinical diagnostician, and a prolific organizer of retinal meetings worldwide. Dr. Yannuzzi is rated as a Distinguished provider by MediFind in the treatment of Central Serous Chorioretinopathy. His top areas of expertise are Central Serous Chorioretinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Adult-Onset Vitelliform Macular Dystrophy (AVMD), and Vitrectomy.

Dr. Spaide specializes in diseases of the retina and vitreous. His particular interests include retinal surgery, Macular Degeneration, Macular Holes, Macular Pucker, Diabetic Retinopathy, and intraocular inflammation. He has published more than 300 articles and 50 book chapters and 9 books about the diagnosis and treatment of Retinal Diseases. He has given lectures around the world.He has a remarkable number of “firsts” in retinal diseases including the development of autofluorescence imaging using a fundus camera and the first practical method to image deeper structures in the eye with optical coherence tomography. These imaging methods now are used around the world. He has described many new findings and diseases of the eye and helped develop many novel treatments. He has developed numerous surgical instruments that were named after him and holds patents for ophthalmic inventions.He is the recipient of the Richard and Hilda Rosenthal Foundation Award in the Visual Sciences, the Senior Honor Award from the American Society of Retinal Surgeons, and the Senior Achievement Award from the American Academy of Opthalmology and the Prix Soubrane de la Recherche en Ophthalmologie, Award of Merit from the Retina Society, the Henkind Award, Coscas Award, Nataraja Pillai Award, W. Richard Green MD Award, George Theodossiadis Award, Founders Award, American Society of Retinal Surgeons, Life Achievement Honor Award, and the American Academy of Ophthalmology. Dr. Spaide is rated as an Elite provider by MediFind in the treatment of Central Serous Chorioretinopathy. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Geographic Atrophy, Central Serous Chorioretinopathy, and Vitrectomy.

Irene A. Barbazetto, M.D. is a vitreoretinal surgeon and macular disease specialist board certified in the United States and Europe. She is an internationally recognized expert in the treatment of macular degeneration, retinal vascular disease, retinal vein occlusion, hereditary retinal disease, and diabetes.The author of more than 40 peer-reviewed articles and book chapters, she serves on the Editorial Board of the prestigious journal Graefe’s Archive of Clinical and Experimental Ophthalmology. Dr. Barbazetto is the recipient of the 2009 Achievement Award from the American Academy of Ophthalmology. Her patients voted her as one of the best retina doctors, America’s “Most Compassionate Physicians,” and she received the “Patient’s Choice Award” in 2010. A graduate of Hamburg University, Germany, Dr. Barbazetto’s doctoral thesis investigated a newly developed vision-screening test (H-Test) for pre-school children and was awarded cum laude. She completed her ophthalmology residency in Lübeck, Germany, where she participated in the development of photodynamic therapy for the treatment of macular degeneration.In 2000, she came to New York for a research fellowship with Dr. Stanley Chang at Columbia University, focusing on the role of oxygen in the development of cataract after vitreoretinal surgery. She completed an internship in general surgery at the Lenox Hill Hospital in Manhattan and an ophthalmology residency at Columbia University. Dr. Barbazetto is rated as a Distinguished provider by MediFind in the treatment of Central Serous Chorioretinopathy. Her top areas of expertise are Central Serous Chorioretinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), and Adult-Onset Vitelliform Macular Dystrophy (AVMD).